— Know what they know.
Not Investment Advice

PTGX NASDAQ

Protagonist Therapeutics, Inc.
1W: -3.4% 1M: -3.4% 3M: +23.3% YTD: +17.0% 1Y: +118.9% 3Y: +301.6% 5Y: +234.8%
$99.19
-2.82 (-2.76%)
 
Weekly Expected Move ±6.0%
$90 $96 $102 $108 $114
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 41 · $6.4B mcap · 52M float · 1.43% daily turnover · Short 77% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -195.2%  ·  5Y Avg: -26.5%
Cost Advantage
49
Intangibles
42
Switching Cost
12
Network Effect
52
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PTGX has No discernible competitive edge (34.4/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -195.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$110
Low
$110
Avg Target
$110
High
Based on 1 analyst since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 25Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$117.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-06 Goldman Sachs Initiated $110 +10.9% $99.21
2026-04-14 Truist Financial Srikripa Devarakonda $110 $121 +11 +17.2% $103.21
2026-03-18 Jefferies Roger Song Initiated $121 +23.8% $97.78
2026-01-30 H.C. Wainwright $50 $117 +67 +46.7% $79.73
2026-01-05 Truist Financial $88 $110 +22 +26.2% $87.18
2025-12-17 Barclays $72 $108 +36 +18.0% $91.54
2025-10-28 Truist Financial Srikripa Devarakonda $76 $88 +12 +14.8% $76.68
2025-10-13 Johnson Rice $74 $112 +38 +28.7% $87.00
2025-10-07 Johnson Rice Initiated $74 +13.0% $65.47
2025-09-16 Barclays Initiated $72 +22.9% $58.59
2025-03-11 Wedbush Initiated $70 +17.1% $59.76
2025-03-11 Truist Financial $60 $76 +16 +27.2% $59.76
2025-03-03 BTIG Initiated $73 +89.6% $38.50
2024-12-05 BMO Capital Etzer Darout Initiated $62 +48.8% $41.68
2024-11-22 Truist Financial Srikripa Devarakonda Initiated $60 +29.1% $46.46
2024-09-12 H.C. Wainwright Douglas Tsao $38 $50 +12 +10.9% $45.08
2024-06-17 H.C. Wainwright Douglas Tsao Initiated $38 +15.6% $32.86

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
4
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PTGX receives an overall rating of C-. Strongest factors: D/E (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-27 D+ C-
2026-04-01 C- D+
2026-03-02 C C-
2026-02-26 B- C
2026-02-24 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

24 Grade D
Profitability
25
Balance Sheet
85
Earnings Quality
76
Growth
12
Value
27
Momentum
20
Safety
100
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PTGX scores highest in Safety (100/100) and lowest in Growth (12/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
80.19
Safe Zone
Piotroski F-Score
1/9
Beneish M-Score
-2.60
Unlikely Manipulator
Ohlson O-Score
-5.43
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 1.02x
Accruals: 0.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PTGX scores 80.19, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PTGX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PTGX's score of -2.60 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PTGX's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PTGX receives an estimated rating of A+ (score: 75.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-56.28x
PEG
0.16x
P/S
86.13x
P/B
9.85x
P/FCF
-63.88x
P/OCF
EV/EBITDA
-51.32x
EV/Revenue
92.80x
EV/EBIT
-50.77x
EV/FCF
-59.09x
Earnings Yield
-1.54%
FCF Yield
-1.57%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PTGX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.994
NI / EBT
×
Interest Burden
0.852
EBT / EBIT
×
EBIT Margin
-1.828
EBIT / Rev
×
Asset Turnover
0.105
Rev / Assets
×
Equity Multiplier
1.097
Assets / Equity
=
ROE
-17.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PTGX's ROE of -17.8% is driven by Asset Turnover (0.105), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.99 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$99.19
Median 1Y
$86.63
5th Pctile
$21.15
95th Pctile
$357.46
Ann. Volatility
91.3%
Analyst Target
$117.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Dinesh V. Patel,
Ph.D. President and Chief Executive Officer
$715,500 $5,839,204 $12,871,506
Arturo Molina, M.D.,
M.S., F.A.C.P. Chief Medical Officer
$572,000 $1,601,610 $4,095,230
Asif Ali EVP,
Chief Financial Officer
$500,000 $1,238,745 $3,257,489

CEO Pay Ratio

38:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,871,506
Avg Employee Cost (SGA/emp): $339,795
Employees: 132

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
132
+4.8% YoY
Revenue / Employee
$348,606
Rev: $46,016,000
Profit / Employee
$-985,977
NI: $-130,149,000
SGA / Employee
$339,795
Avg labor cost proxy
R&D / Employee
$1,206,742
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -45.3% -59.8% -43.3% -42.3% -45.8% -44.9% -49.4% -54.4% -53.4% -54.5% -28.6% 58.7% 61.5% 61.9% 54.4% 11.1% 10.3% 9.1% -20.2% -17.8% -17.78%
ROA -34.0% -44.9% -37.4% -36.4% -39.5% -38.7% -42.8% -47.1% -46.2% -47.2% -26.1% 53.5% 56.1% 56.4% 49.9% 10.2% 9.4% 8.3% -18.4% -16.2% -16.22%
ROIC 3.2% 4.2% 4.8% 4.7% 5.1% 5.0% 5.7% 6.4% 6.4% 6.7% 19.5% -38.3% -39.5% -38.7% 93.2% 10.0% 8.7% 6.8% -2.2% -2.0% -1.95%
ROCE -28.7% -37.9% -41.7% -40.7% -44.0% -43.5% -58.5% -65.5% -66.1% -68.9% -27.8% 44.2% 45.2% 44.3% 36.3% 3.9% 3.4% 3.7% -24.2% -21.7% -21.68%
Gross Margin 1.0% 1.0% 90.5% 96.8% 1.9% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 99.3% 99.28%
Operating Margin -13.6% -3.3% -4.4% -82.1% -48.2% 38.4% 80.9% -9.3% -8.9% 74.3% -68.2% -7.6% -9.9% -6.8% -6.5% -6.47%
Net Margin -13.6% -3.3% -4.3% -81.4% -47.8% 45.6% 81.3% -7.3% -7.1% 77.2% -41.2% -6.3% -8.3% -6.0% 6.7% 6.71%
EBITDA Margin -13.6% -3.2% -4.3% -78.1% -46.8% 39.8% 81.0% -9.0% -8.7% 74.6% -67.3% -7.5% -8.3% -6.7% -5.7% -5.75%
FCF Margin -3.2% -4.1% -4.0% -2.5% -2.4% -3.0% -4.1% -122.6% -1.2% -20.4% 72.3% 70.8% 42.1% 1.6% 17.7% 30.5% 1.3% -1.6% -1.57%
OCF Margin -3.2% -4.1% -3.9% -2.5% -2.3% -2.9% -4.1% -122.0% -1.2% -20.1% 72.6% 71.1% 42.4% 1.6% 18.9% 31.3% 1.3% -1.6% -1.57%
ROE 3Y Avg snapshot only 12.60%
ROE 5Y Avg snapshot only -13.61%
ROA 3Y Avg snapshot only 11.90%
ROIC Economic snapshot only -18.05%
Cash ROA snapshot only -17.41%
Cash ROIC snapshot only -2.02%
CROIC snapshot only -2.02%
NOPAT Margin snapshot only -1.52%
Pretax Margin snapshot only -1.56%
R&D / Revenue snapshot only 2.30%
SGA / Revenue snapshot only 62.64%
SBC / Revenue snapshot only 48.79%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -24.71 -7.91 -13.12 -9.43 -2.92 -3.18 -4.22 -8.30 -11.40 -7.03 -17.95 11.35 12.50 16.27 9.31 54.19 67.46 92.28 -42.66 -64.77 -56.281
P/S Ratio 73.98 34.86 60.20 24.62 8.53 11.76 20.22 1354.13 23.62 5.84 6.66 8.58 5.90 14.65 16.78 20.25 120.66 100.32 86.130
P/B Ratio 7.20 3.04 5.49 3.85 1.29 1.38 2.49 5.39 7.27 4.58 4.21 5.46 6.31 8.26 3.80 4.51 5.20 6.27 9.03 12.09 9.849
P/FCF -22.76 -8.43 -15.11 -9.78 -3.60 -3.97 -4.93 -11.04 -13.31 -8.26 -20.00 -28.68 9.20 12.13 14.02 9.08 94.62 66.49 96.28 -63.88 -63.883
P/OCF 9.17 12.07 13.92 9.04 88.77 64.71 96.28
EV/EBITDA -21.38 -5.18 -10.63 -6.89 -0.51 -0.72 -2.46 -6.71 -9.54 -5.16 -11.92 9.90 11.46 16.01 8.43 87.54 120.70 139.06 -33.36 -51.32 -51.315
EV/Revenue 62.96 22.57 48.46 17.77 1.47 2.64 11.43 1082.07 17.94 4.76 5.59 7.53 4.96 12.69 14.83 18.30 108.56 92.80 92.798
EV/EBIT -21.03 -5.11 -10.47 -6.75 -0.50 -0.70 -2.40 -6.55 -9.32 -5.05 -11.49 10.08 11.72 16.36 8.52 96.86 129.39 146.74 -33.07 -50.77 -50.766
EV/FCF -19.37 -5.46 -12.17 -7.06 -0.62 -0.89 -2.79 -8.82 -11.32 -6.31 -15.20 -23.37 7.73 10.64 11.79 7.86 83.62 60.09 86.62 -59.09 -59.094
Earnings Yield -4.0% -12.6% -7.6% -10.6% -34.2% -31.4% -23.7% -12.1% -8.8% -14.2% -5.6% 8.8% 8.0% 6.1% 10.7% 1.8% 1.5% 1.1% -2.3% -1.5% -1.54%
FCF Yield -4.4% -11.9% -6.6% -10.2% -27.8% -25.2% -20.3% -9.1% -7.5% -12.1% -5.0% -3.5% 10.9% 8.2% 7.1% 11.0% 1.1% 1.5% 1.0% -1.6% -1.57%
PEG Ratio snapshot only 0.156
Price/Tangible Book snapshot only 12.087
EV/Gross Profit snapshot only 93.311
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.84 7.84 7.74 7.74 7.74 7.74 7.80 7.80 7.80 7.80 16.71 16.71 16.71 16.71 12.48 12.48 12.48 12.48 12.71 12.71 12.710
Quick Ratio 7.84 7.84 7.74 7.74 7.74 7.74 7.80 7.80 7.80 7.80 16.71 16.71 16.71 16.71 12.48 12.48 12.48 12.48 12.71 12.71 12.710
Debt/Equity 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.017
Net Debt/Equity -1.07 -1.07 -1.07 -1.07 -1.07 -1.07 -1.08 -1.08 -1.08 -1.08 -1.01 -1.01 -1.01 -1.01 -0.60 -0.60 -0.60 -0.60 -0.91 -0.91 -0.906
Debt/Assets 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.015
Debt/EBITDA -0.07 -0.06 -0.05 -0.05 -0.04 -0.05 -0.03 -0.03 -0.03 -0.03 -0.01 0.01 0.01 0.01 0.04 0.36 0.42 0.39 -0.07 -0.08 -0.077
Net Debt/EBITDA 3.74 2.82 2.57 2.65 2.46 2.49 1.89 1.69 1.67 1.60 3.77 -2.25 -2.19 -2.24 -1.60 -13.55 -15.88 -14.82 3.72 4.16 4.159
Interest Coverage -558.25 -847.71
Equity Multiplier 1.16 1.16 1.16 1.16 1.16 1.16 1.15 1.15 1.15 1.15 1.06 1.06 1.06 1.06 1.10 1.10 1.10 1.10 1.09 1.09 1.090
Cash Ratio snapshot only 12.486
Cash to Debt snapshot only 54.961
FCF to Debt snapshot only -11.267
Defensive Interval snapshot only 965.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.11 0.10 0.08 0.14 0.14 0.10 0.09 0.00 0.00 0.00 0.20 1.04 1.05 1.07 0.79 0.38 0.38 0.38 0.07 0.10 0.105
Inventory Turnover
Receivables Turnover 5.93 5.31 13.71 23.49 22.79 17.63 33.73 1.09 0.00 0.00 11.99 62.93 63.76 64.69 4.96 2.37 2.39 2.39 0.56 0.90 0.897
Payables Turnover 0.00 0.00 0.35 0.71 1.07 1.07 0.64 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.117
DSO 62 69 27 16 16 21 11 335 30 6 6 6 74 154 153 153 655 407 406.9 days
DIO 0 0 0 0 0 0 0 0.0 days
DPO 1042 516 342 342 571 1134 3118 3118.2 days
Cash Conversion Cycle -1015 -501 -326 -321 -560 -800 -2711 -2711.3 days
Fixed Asset Turnover snapshot only 6.336
Cash Velocity snapshot only 0.131
Capital Intensity snapshot only 9.045
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 62.7% -5.1% -4.4% 50.4% 67.1% 44.3% -2.8% -98.2% -1.0% -1.0% 1.3% 365.7% 6.2% -34.0% -34.5% -35.4% -89.4% -64.4% -64.36%
Net Income -11.0% -66.0% -89.8% -74.8% -62.8% -21.0% -1.5% -14.5% -3.7% -8.0% 38.0% 2.2% 2.2% 2.2% 4.5% -65.3% -69.4% -73.1% -1.5% -3.0% -3.04%
EPS 18.8% -29.4% -56.1% -58.6% -48.9% -18.2% 0.8% -10.3% 10.4% 10.4% 50.6% 1.9% 2.1% 2.2% 4.2% -65.0% -70.4% -74.0% -1.5% -2.8% -2.82%
FCF -33.9% -47.3% -49.4% -37.4% -21.8% -3.5% 0.0% 10.7% -9.4% -14.5% 35.0% 39.1% 3.0% 2.9% 3.6% 6.2% -83.9% -72.2% -68.5% -1.3% -1.35%
EBITDA -21.2% -85.0% -1.0% -80.9% -62.8% -21.2% 1.1% -14.5% -7.2% -13.4% 26.8% 2.1% 2.1% 2.0% 3.8% -80.1% -83.5% -81.9% -1.6% -5.4% -5.45%
Op. Income -12.6% -70.9% -96.5% -79.9% -64.9% -23.3% -3.7% -18.1% -9.5% -15.4% 28.7% 2.0% 2.0% 2.0% 3.7% -81.7% -84.3% -87.3% -1.6% -6.2% -6.23%
OCF Growth snapshot only -1.35%
Asset Growth snapshot only -10.05%
Equity Growth snapshot only -8.97%
Debt Growth snapshot only -5.00%
Shares Change snapshot only 11.96%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -13.8% -15.1% -4.0% 29.3% 1.9% 3.9% -28.2% 28.0% 1.2% 1.3% 1.4% 1.5% 64.3% 66.3% 81.1% 20.1% 3.4% 3.42%
Revenue 5Y 32.0% 5.8% -51.1% 14.2% 70.7% 1.8% 3.5% 1.5% 65.7% 52.1% 10.0% 18.9% 18.90%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -13.8% -15.1% -5.0% 27.7% 28.0% 1.2% 1.3% 1.4% 1.5% 66.2% 69.5% 85.6% 22.7% 15.6% 15.64%
Gross Profit 5Y 30.1% 4.4% -78.0% 14.2% 70.7% 65.7% 52.1% 10.0% 18.8% 18.77%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 25.6% 25.6% 35.6% 35.6% 35.6% 35.6% 17.0% 17.0% 17.0% 17.0% 3.3% 3.3% 3.3% 3.3% 28.9% 28.9% 28.9% 28.9% 39.3% 39.3% 39.28%
Assets 5Y 85.3% 29.9% 29.9% 29.9% 29.9% 8.7% 8.7% 8.7% 8.7% 20.7% 20.7% 20.7% 20.7% 36.9% 36.9% 36.9% 36.9% 15.6% 15.6% 15.60%
Equity 3Y 39.2% 39.2% 39.2% 39.2% 6.4% 6.4% 6.4% 6.4% 31.1% 31.1% 31.1% 31.1% 41.8% 41.8% 41.80%
Book Value 3Y 14.8% 13.9% 15.9% 19.4% -8.3% -5.7% -4.1% -2.2% 17.7% 20.3% 20.2% 20.1% 30.2% 26.9% 26.94%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.05 0.15 0.33 0.66 0.86 0.64 0.20 0.02 0.25 0.51 0.30 0.38 0.43 0.43 0.52 0.54 0.50 0.47 0.15 0.15 0.145
Earnings Stability 0.65 0.83 0.85 0.84 0.78 0.84 0.87 0.92 0.93 0.93 0.40 0.16 0.19 0.20 0.36 0.39 0.37 0.36 0.10 0.07 0.074
Margin Stability 0.00 1.00 0.00 0.14 0.00 0.96 0.00 0.00 0.97 0.96 0.97 0.45 0.00 0.96 0.00 0.00 0.97 0.96 0.97 0.45 0.454
Rev. Growth Consistency 1.00 0.00 0.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0
Earnings Persistence 0.96 0.50 0.50 0.50 0.50 0.92 0.99 0.94 0.99 0.97 0.85 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.20 0.200
Earnings Smoothness 0.03 0.00 0.00
ROE Trend 0.18 0.24 0.16 0.16 -0.26 -0.32 -0.27 -0.24 0.27 1.01 1.05 1.05 0.82 0.17 0.14 0.14 -0.30 -0.47 -0.469
Gross Margin Trend 0.75 5.97 0.56 -0.05 -0.07 -0.05 -0.96 0.05 0.51 0.03 0.49 0.00 -0.01 -0.005
FCF Margin Trend 7.87 89.27 7.85 1.23 0.43 -0.83 -120.01 2.86 62.38 3.06 63.04 1.63 -2.28 -2.275
Sustainable Growth Rate 58.7% 61.5% 61.9% 54.4% 11.1% 10.3% 9.1%
Internal Growth Rate 1.2% 1.3% 1.3% 99.7% 11.3% 10.4% 9.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.08 0.93 0.86 0.95 0.80 0.80 0.85 0.75 0.85 0.85 0.89 -0.39 1.36 1.35 0.67 6.00 0.76 1.43 -0.44 1.02 1.017
FCF/OCF 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.01 1.01 1.01 1.00 1.00 0.99 1.00 0.94 0.97 1.00 1.00 0.997
FCF/Net Income snapshot only 1.014
CapEx/Revenue 3.1% 4.2% 4.0% 2.6% 2.3% 2.6% 3.0% 61.9% 1.0% 0.3% 0.2% 0.3% 0.3% 0.8% 1.2% 0.8% 0.0% 0.4% 0.45%
CapEx/Depreciation snapshot only 0.228
Accruals Ratio 0.03 -0.03 -0.05 -0.02 -0.08 -0.08 -0.06 -0.12 -0.07 -0.07 -0.03 0.74 -0.20 -0.20 0.17 -0.51 0.02 -0.04 -0.27 0.00 0.003
Sloan Accruals snapshot only -0.019
Cash Flow Adequacy snapshot only -353.439
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -12.8% -29.8% -7.7% -12.1% -4.2% -3.8% -3.0% -2.2% -8.5% -13.4% -9.3% -6.3% -0.5% -0.8% -0.9% -0.9% -0.8% -0.5% -0.4% -0.5% -0.47%
Total Shareholder Return -12.8% -29.8% -7.7% -12.1% -4.2% -3.8% -3.0% -2.2% -8.5% -13.4% -9.3% -6.3% -0.5% -0.8% -0.9% -0.9% -0.8% -0.5% -0.4% -0.5% -0.47%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 1.00 1.00 1.00 0.98 0.98 0.99 0.98 0.98 0.97 0.96 1.01 0.99 0.994
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 0.99 1.00 0.99 0.96 0.94 0.84 1.11 1.13 1.16 1.11 2.10 2.24 1.84 0.86 0.85 0.852
EBIT Margin -2.99 -4.41 -4.63 -2.63 -2.94 -3.75 -4.77 -165.19 -1.56 0.47 0.48 0.46 0.58 0.13 0.11 0.12 -3.28 -1.83 -1.828
Asset Turnover 0.11 0.10 0.08 0.14 0.14 0.10 0.09 0.00 0.00 0.00 0.20 1.04 1.05 1.07 0.79 0.38 0.38 0.38 0.07 0.10 0.105
Equity Multiplier 1.33 1.33 1.16 1.16 1.16 1.16 1.16 1.16 1.16 1.16 1.10 1.10 1.10 1.10 1.09 1.09 1.09 1.09 1.10 1.10 1.097
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.82 $-2.24 $-2.61 $-2.51 $-2.70 $-2.65 $-2.59 $-2.77 $-2.42 $-2.37 $-1.28 $2.55 $2.77 $2.77 $4.14 $0.89 $0.82 $0.72 $-2.05 $-1.63 $-1.63
Book Value/Share $6.23 $5.83 $6.23 $6.15 $6.12 $6.11 $4.38 $4.26 $3.80 $3.64 $5.45 $5.29 $5.49 $5.45 $10.17 $10.73 $10.63 $10.59 $9.67 $8.72 $10.07
Tangible Book/Share $6.23 $5.83 $6.23 $6.15 $6.12 $6.11 $4.38 $4.26 $3.80 $3.64 $5.45 $5.29 $5.49 $5.45 $10.17 $10.73 $10.63 $10.59 $9.67 $8.72 $8.72
Revenue/Share $0.61 $0.51 $0.57 $0.96 $0.93 $0.72 $0.54 $0.02 $0.00 $0.00 $0.97 $4.95 $5.21 $5.24 $6.54 $3.30 $3.29 $3.28 $0.72 $1.05 $1.14
FCF/Share $-1.97 $-2.10 $-2.26 $-2.42 $-2.20 $-2.13 $-2.21 $-2.08 $-2.08 $-2.02 $-1.15 $-1.01 $3.77 $3.71 $2.75 $5.33 $0.58 $1.00 $0.91 $-1.65 $-1.79
OCF/Share $-1.95 $-2.08 $-2.24 $-2.40 $-2.18 $-2.11 $-2.20 $-2.07 $-2.07 $-2.01 $-1.14 $-1.00 $3.78 $3.73 $2.77 $5.35 $0.62 $1.03 $0.91 $-1.65 $-1.79
Cash/Share $6.82 $6.37 $6.79 $6.71 $6.66 $6.66 $4.82 $4.69 $4.18 $4.01 $5.53 $5.37 $5.57 $5.53 $6.31 $6.65 $6.60 $6.57 $8.92 $8.05 $8.42
EBITDA/Share $-1.79 $-2.21 $-2.59 $-2.48 $-2.66 $-2.62 $-2.51 $-2.74 $-2.46 $-2.47 $-1.46 $2.38 $2.54 $2.47 $3.85 $0.48 $0.40 $0.43 $-2.36 $-1.90 $-1.90
Debt/Share $0.13 $0.12 $0.12 $0.12 $0.12 $0.12 $0.07 $0.07 $0.06 $0.06 $0.02 $0.02 $0.02 $0.02 $0.16 $0.17 $0.17 $0.17 $0.16 $0.15 $0.15
Net Debt/Share $-6.68 $-6.25 $-6.67 $-6.59 $-6.55 $-6.54 $-4.74 $-4.62 $-4.12 $-3.95 $-5.51 $-5.35 $-5.55 $-5.51 $-6.14 $-6.48 $-6.42 $-6.40 $-8.76 $-7.90 $-7.90
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 80.194
Altman Z-Prime snapshot only 142.928
Piotroski F-Score 4 3 2 3 3 3 3 2 2 2 5 5 7 7 5 5 3 4 4 1 1
Beneish M-Score -3.02 -3.18 -2.59 -0.58 26.26 125.20 249.06 129.28 132.36 -10.05 -2.60 -2.596
Ohlson O-Score snapshot only -5.430
ROIC (Greenblatt) snapshot only -24.89%
Net-Net WC snapshot only $7.41
EVA snapshot only $-118313950.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 60.96 61.06 74.12 74.77 69.38 69.76 76.78 76.20 76.41 76.48 76.71 88.14 94.74 94.35 94.62 94.51 94.43 94.08 83.13 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only -18.902
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms